Could cord cell secretions ease arthritis pain?
NCT ID NCT07715045
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests whether a substance produced by umbilical cord cells can help control moderate rheumatoid arthritis. Participants receive weekly injections of either the cell substance or a placebo for six weeks, alongside their usual medication. The goal is to see if it improves symptoms and reduces inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a substance from umbilical cord cells (UC-MSC secretome)
- What this could lead to
- If it works, this could offer a new way to control rheumatoid arthritis symptoms for people who don't respond well to standard drugs.
- What could go wrong
- This is a small, early-phase trial, so results may not apply to everyone. The treatment is still experimental and may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Mohammad Hoesin General Hospital
Palembang, South Sumatera, 30126, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Which RA drug works best after the first one fails? a major trial aims to find out
- Could a once-every-few-weeks IV infusion tame rheumatoid arthritis?
- CT scans track hip implant movement to predict Long-Term stability
- Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors